{"id":57888,"date":"2026-02-26T02:15:28","date_gmt":"2026-02-26T02:15:28","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/pharmaceutical-contract-manufacturing-and-research-services-mordor\/"},"modified":"2026-09-18T22:19:49","modified_gmt":"2026-09-18T13:19:49","slug":"pharmaceutical-contract-manufacturing-and-research-services-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/pharmaceutical-contract-manufacturing-and-research-services-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025-2030)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/pharmaceutical-contract-manufacturing-and-research-services_1651818825583_PCMR1.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/pharmaceutical-contract-manufacturing-and-research-services-size-image-1763922706826.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \uc5ed\ud559<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc758\uc57d\ud488 \uac1c\ubc1c \uc218\uc694 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \ub0ae\uc740 \uc81c\uc870 \ube44\uc6a9 \ubc0f \uac1c\ubc1c\ub3c4\uc0c1\uad6d\uc758 \uacbd\uc81c \uc0c1\ud669 \uac1c\uc120<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc0ac\uc6a9 \uc99d\uac00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc758\uc57d\ud488 \uc2b9\uc778 \uad00\ub828 \uaddc\uc81c \ubb38\uc81c<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc81c\uc57d \ud68c\uc0ac\uc758 \uc81c\ud55c\uc801\uc778 \uc544\uc6c3\uc18c\uc2f1 \uc120\ud0dd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uc138\ubd84\ud654 (\uac00\uce58 \uae30\uc900 \uc2dc\uc7a5 \uaddc\ubaa8 &#8211; \ubc31\ub9cc USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\uc870 \uc11c\ube44\uc2a4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 API\/\uc6d0\ub8cc \uc758\uc57d\ud488<\/li>\n<li class=\"toc-level-3\">5.1.2 \ucca8\ub2e8 \uc57d\ubb3c \uc804\ub2ec \uc81c\ud615 \ud3ec\uc7a5<\/li>\n<li class=\"toc-level-3\">5.1.3 \ud3ec\uc7a5<\/li>\n<li class=\"toc-level-3\">5.1.4 \uc644\uc81c \uc758\uc57d\ud488 \uc81c\ud615<\/li>\n<li class=\"toc-level-4\">5.1.4.1 \uace0\ud615 \uc81c\ud615<\/li>\n<li class=\"toc-level-4\">5.1.4.2 \uc561\uc0c1 \uc81c\ud615<\/li>\n<li class=\"toc-level-4\">5.1.4.3 \ubc18\uace0\ud615 \uc81c\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc5f0\uad6c \uc11c\ube44\uc2a4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.2.2 \ubc31\uc2e0<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc5fc\uc99d \ubc0f \uba74\uc5ed\ud559<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc2ec\uc7a5\ud559<\/li>\n<li class=\"toc-level-3\">5.2.5 \uc2e0\uacbd\uacfc\ud559<\/li>\n<li class=\"toc-level-3\">5.2.6 \uae30\ud0c0 \uc5f0\uad6c \uc11c\ube44\uc2a4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.3.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.3.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.3.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.3.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.3.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.3.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.3.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.3.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.3.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li><strong>Introduction to Korean Language:<\/strong> This section introduces the basics of the Korean language, including its history, unique characteristics, and global significance. It covers the Korean alphabet (Hangul), basic sentence structure, and common phrases.<\/li>\n<li><strong>Hangul Mastery:<\/strong> A comprehensive guide to learning Hangul, the Korean alphabet. This section breaks down consonants and vowels, their pronunciation, and how they combine to form syllables. It includes practice exercises for reading and writing.<\/li>\n<li><strong>Essential Korean Grammar:<\/strong> Dive into the core grammatical structures of Korean. Topics include particles, verb conjugations, honorifics, tenses, and common sentence patterns. Each concept is explained with clear examples and practical usage tips.<\/li>\n<li><strong>Vocabulary Building:<\/strong> Expand your Korean lexicon with themed vocabulary lists. This section covers everyday words, common verbs and adjectives, numbers, time, and expressions for various situations like travel, shopping, and dining.<\/li>\n<li><strong>Practical Conversation Skills:<\/strong> Learn how to engage in basic conversations. This section focuses on greetings, self-introductions, asking and answering questions, expressing opinions, and making requests. Role-playing scenarios and dialogue examples are provided.<\/li>\n<li><strong>Korean Culture and Etiquette:<\/strong> Understand the cultural context of the language. This section explores Korean customs, social norms, dining etiquette, traditional holidays, and the importance of honorifics in communication, helping learners navigate social interactions respectfully.<\/li>\n<li><strong>Listening and Speaking Practice:<\/strong> Develop your auditory comprehension and oral fluency. This section offers audio exercises, pronunciation drills, and tips for improving listening skills. It encourages active speaking practice through<br \/>\n","protected":false},"excerpt":{"rendered":"<p>\uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5 \uac1c\uc694 (2025-2030\ub144)<\/p>\n<p>Mordor Intelligence\uc758 \ubd84\uc11d\uc5d0 \ub530\ub974\uba74, \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.00%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774 \uc2dc\uc7a5\uc740 \uc81c\uc870 \uc11c\ube44\uc2a4(API\/\uc6d0\ub8cc\uc758\uc57d\ud488, \ucca8\ub2e8 \uc57d\ubb3c \uc804\ub2ec \uc81c\ud615 \ud3ec\uc7a5, \ud3ec\uc7a5, \uc644\uc81c \uc758\uc57d\ud488)\uc640 \uc5f0\uad6c \uc11c\ube44\uc2a4(\uc885\uc591\ud559, \ubc31\uc2e0, \uc5fc\uc99d \ubc0f \uba74\uc5ed\ud559, \uc2ec\uc7a5\ud559 \ub4f1)\ub85c \uc138\ubd84\ud654\ub429\ub2c8\ub2e4. \uc9c0\ub9ac\uc801\uc73c\ub85c\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ub4f1\uc73c\ub85c \ub098\ub258\uba70, \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc744 \ud615\uc131\ud558\uace0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc774\uba70, \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 Thermo Fisher Scientific (PPD, Inc.), AbbVie, Baxter BioPharma, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmbH \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ubd84\uc11d<\/p>\n<p>COVID-19 \ud32c\ub370\ubbf9\uc740 \uc2dc\uc7a5\uc5d0 \uc0c1\ub2f9\ud55c \uc601\ud5a5\uc744 \ubbf8\ucce4\uc2b5\ub2c8\ub2e4. \ud32c\ub370\ubbf9 \ucd08\uae30\uc5d0\ub294 \uc81c\uc57d \uc0b0\uc5c5\uc758 \uacf5\uae09\ub9dd \ubc0f \uc720\ud1b5 \ucc44\ub110\uc5d0 \ubd80\uc815\uc801\uc778 \uc601\ud5a5\uc744 \uc8fc\uc5c8\uc73c\ub098, \ub3d9\uc2dc\uc5d0 \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \ucd09\uc9c4\ud558\ub294 \uacc4\uae30\uac00 \ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2020\ub144 12\uc6d4 CDMO(Contract Development and Manufacturing Organization) \uae30\uc5c5\uc778 Recipharm\uc740 Moderna\uc640 \uacc4\uc57d\uc744 \uccb4\uacb0\ud558\uc5ec \ubbf8\uad6d \uc678 \uc9c0\uc5ed\uc5d0 \uacf5\uae09\ub420 Moderna COVID-19 \ubc31\uc2e0\uc758 \ucda9\uc804 \ubc0f \uc644\uc81c \uacf5\uc815\uc744 \uc9c0\uc6d0\ud588\uc2b5\ub2c8\ub2e4. \ub610\ud55c, 2021\ub144 1\uc6d4 ICON PLC\ub294 Pfizer Inc. \ubc0f BioNTech\uc640 \ud611\ub825\ud558\uc5ec COVID-19 \ubc31\uc2e0 \ud504\ub85c\uadf8\ub7a8 \uac1c\ubc1c\uc744 \uc704\ud55c \uc784\uc0c1 \uc2dc\ud5d8 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud588\uc2b5\ub2c8\ub2e4. ICON\uc740 \uc720\ub7fd, \ub0a8\uc544\ud504\ub9ac\uce74, \ubbf8\uad6d, \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74\uc758 153\uac1c \uc774\uc0c1\uc758 \uc0ac\uc774\ud2b8\uc5d0\uc11c 44,000\uba85\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \ucc38\uac00\uc790\ub97c \ubaa8\uc9d1\ud558\uace0, \ud604\uc7a5 \uad50\uc721, \ubb38\uc11c \uad00\ub9ac, \ud658\uc790 \ub3d9\uc758\uc11c \uac80\ud1a0\ub97c \uc704\ud55c \uc6b4\uc601 \uc9c0\uc6d0\uc744 \uc81c\uacf5\ud588\uc2b5\ub2c8\ub2e4. \uc774\ucc98\ub7fc \ud32c\ub370\ubbf9\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\ucce4\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc740 \uc758\uc57d\ud488 \uac1c\ubc1c \uc218\uc694 \uc99d\uac00, \ub0ae\uc740 \uc81c\uc870 \ube44\uc6a9, \uac1c\ubc1c\ub3c4\uc0c1\uad6d\uc758 \uacbd\uc81c \uc0c1\ud669 \uac1c\uc120, \uadf8\ub9ac\uace0 \ubc14\uc774\uc624\uc758\uc57d\ud488 \uc0ac\uc6a9 \uc99d\uac00\uc785\ub2c8\ub2e4. \uc2e0\uc57d \uac1c\ubc1c \uc218\uc694 \uc99d\uac00\ub294 \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc73c\uba70, \uc5ec\ub7ec \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc740 \uc804\ub7b5\uc801 \uc774\ub2c8\uc154\ud2f0\ube0c\ub97c \ud65c\ubc1c\ud788 \ucd94\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ub840\ub85c, 2020\ub144 10\uc6d4 PPD Inc.\ub294 \uc911\uad6d \uc464\uc800\uc6b0\uc5d0 \uc0c8\ub85c\uc6b4 \ub2e4\ubaa9\uc801 \uc784\uc0c1 \uc5f0\uad6c\uc18c\ub97c \uac1c\uc124\ud558\uc5ec \ubaa8\ub4e0 \ub2e8\uacc4\uc758 \uc81c\uc57d \uac1c\ubc1c\uc744 \uc704\ud55c \uc0dd\uccb4 \ubd84\uc11d, \ubc14\uc774\uc624\ub9c8\ucee4, \ubc31\uc2e0 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud568\uc73c\ub85c\uc368 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud588\uc2b5\ub2c8\ub2e4. 2021\ub144 10\uc6d4\uc5d0\ub294 \ub9de\ucda4\ud615 \uce58\ub8cc\ubc95 \ubc0f \ubcf5\uc7a1\ud55c \uc784\uc0c1 \ud504\ub85c\uadf8\ub7a8 \uc804\ubb38 CRO(Contract Research Organization)\uc778 CTI Clinical Trial &#038; Consulting Services (CTI)\uac00 \uc57d\ubb3c \uac1c\ubc1c\uc758 \ubaa8\ub4e0 \ub2e8\uacc4\uc5d0\uc11c \uc81c\uc57d \ubc0f \ubc14\uc774\uc624\ud14d \ud30c\ud2b8\ub108\ub97c \uc9c0\uc6d0\ud558\ub294 \uae00\ub85c\ubc8c CRO\uc778 BioAgilytix\uc640 \uacf5\uc2dd\uc801\uc778 \uc804 \uc138\uacc4 \ud30c\ud2b8\ub108\uc2ed \uacc4\uc57d\uc744 \uccb4\uacb0\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ub610\ud55c, \ubbf8\uad6d \uc81c\uc57d \uc5f0\uad6c \ubc0f \uc81c\uc870\uc5c5\uccb4 \ud611\ud68c(PhRMA)\uc758 2020\ub144 9\uc6d4 \uc5c5\ub370\uc774\ud2b8\uc5d0 \ub530\ub974\uba74, PhRMA \ud68c\uc6d0\uc0ac\ub4e4\uc740 2019\ub144\uc5d0 \uc57d 830\uc5b5 \ub2ec\ub7ec\ub97c R&#038;D \ud65c\ub3d9\uc5d0 \ud22c\uc790\ud588\uc2b5\ub2c8\ub2e4. \uac19\uc740 \uc790\ub8cc\uc5d0 \ub530\ub974\uba74, 2020\ub144 \uae30\uc900\uc73c\ub85c \ubc14\uc774\uc624 \uc81c\uc57d \ud68c\uc0ac\ub4e4\uc774 COVID-19\ub97c \ud3ec\ud568\ud55c \ub2e4\uc591\ud55c \uc9c8\ubcd1\uc5d0 \ub300\ud574 260\uac1c \uc774\uc0c1\uc758 \ubc31\uc2e0\uc744 \uac1c\ubc1c \uc911\uc785\ub2c8\ub2e4. \uacbd\uc81c\ud611\ub825\uac1c\ubc1c\uae30\uad6c(OECD)\uc5d0 \ub530\ub974\uba74, 2020\ub144 GDP \ub300\ube44 \uc758\uc57d\ud488 \uc9c0\ucd9c \ube44\uc911\uc740 \ub124\ub35c\ub780\ub4dc 6.9%, \ub178\ub974\uc6e8\uc774 7.2%, \uc544\uc774\uc2ac\ub780\ub4dc 11.1%, \ud540\ub780\ub4dc 12.4%, \ud55c\uad6d 19.3%\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uadf8\ub7ec\ub098 \uc758\uc57d\ud488 \uc2b9\uc778\uacfc \uad00\ub828\ub41c \uaddc\uc81c \ubb38\uc81c\uc640 \uc81c\uc57d \ud68c\uc0ac\ub4e4\uc758 \uc81c\ud55c\uc801\uc778 \uc544\uc6c3\uc18c\uc2f1 \uc120\ud0dd\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p>\uc885\uc591\ud559 \ubd80\ubb38, \uc2dc\uc7a5\uc5d0\uc11c \uc8fc\uc694 \uc810\uc720\uc728 \ucc28\uc9c0 \uc608\uc0c1<br \/>\n\uc885\uc591\ud559 \ubd80\ubb38\uc740 \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc5d0\uc11c \uc8fc\uc694 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc554 \uc720\ubcd1\ub960 \uc99d\uac00\uc640 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc758 \uc774\ub2c8\uc154\ud2f0\ube0c \uc99d\uac00\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \uc138\uacc4\ubcf4\uac74\uae30\uad6c(WHO)\uc5d0 \ub530\ub974\uba74, 2020\ub144 \uc554\uc73c\ub85c \uc778\ud55c \uc0ac\ub9dd\uc790\ub294 \uc57d 1\ucc9c\ub9cc \uba85\uc73c\ub85c, \uc804\uccb4 \uc0ac\ub9dd\uc790\uc758 \uc57d 6\ubd84\uc758 1\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \ub610\ud55c, GLOBOCAN 2020\uc5d0 \ub530\ub974\uba74, \uc804 \uc138\uacc4 \uc2e0\uaddc \uc554 \ud658\uc790 \uc218\ub294 2040\ub144\uae4c\uc9c0 3,020\ub9cc \uba85\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ub192\uc740 \uc218\uce58\ub294 \uc554 \uc720\ubcd1\ub960 \uc99d\uac00\uac00 \uc81c\uc57d \uc704\ud0c1 \uc5f0\uad6c \uc11c\ube44\uc2a4\uc758 \ud544\uc694\uc131\uc744 \uc99d\ub300\uc2dc\ucf1c \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>\ub610\ud55c, \uc5ec\ub7ec \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc774 \uc804\ub7b5\uc801 \uc774\ub2c8\uc154\ud2f0\ube0c\ub97c \uc801\uadf9\uc801\uc73c\ub85c \ucd94\uc9c4\ud558\uba70 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2021\ub144 2\uc6d4 Parexel\uacfc NeoGenomics\ub294 \uc885\uc591\ud559 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0\uc11c \uc815\ubc00 \uc758\ud559 \uc801\uc6a9\uc744 \ubc1c\uc804\uc2dc\ud0a4\uae30 \uc704\ud55c \uc804\ub7b5\uc801 \ud30c\ud2b8\ub108\uc2ed\uc744 \uccb4\uacb0\ud588\uc2b5\ub2c8\ub2e4. \uc774 \ud30c\ud2b8\ub108\uc2ed\uc740 \uc2e4\uc81c \uc720\uc804\uccb4\ud559 \ub370\uc774\ud130\ub97c \ud65c\uc6a9\ud558\uc5ec \ud658\uc790 \ub9e4\uce6d\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc2dc\ud5d8 \uc124\uacc4, \uc0ac\uc774\ud2b8 \uc120\uc815, \uc784\uc0c1 \uac1c\ubc1c \ubc0f \uc911\uac1c \uc5f0\uad6c\ub97c \ucd5c\uc801\ud654\ud558\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4.<\/p>\n<p>\ubd81\ubbf8 \uc9c0\uc5ed, \uc2dc\uc7a5\uc5d0\uc11c \uc0c1\ub2f9\ud55c \uc810\uc720\uc728 \uc720\uc9c0 \uc608\uc0c1<br \/>\n\ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uc2dc\uc7a5\uc5d0\uc11c \uc0c1\ub2f9\ud55c \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc608\uce21 \uae30\uac04 \ub3d9\uc548\uc5d0\ub3c4 \uc774\ub7ec\ud55c \ucd94\uc138\ub97c \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \ub9cc\uc131 \uc9c8\ud658\uc758 \ub192\uc740 \ubd80\ub2f4\uacfc \ud2b9\ud788 \ubbf8\uad6d \ub0b4 \uc8fc\uc694 \uc9c0\uc5ed \ud50c\ub808\uc774\uc5b4\ub4e4\uc758 \ud65c\ub3d9\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \ubbf8\uad6d \uc554 \ud559\ud68c(American Cancer Society)\uc5d0 \ub530\ub974\uba74, 2022\ub144 \ubbf8\uad6d\uc5d0\uc11c\ub294 \uc57d 190\ub9cc \uac74\uc758 \uc0c8\ub85c\uc6b4 \uc554 \uc0ac\ub840\uac00 \uc9c4\ub2e8\ub418\uace0 609,360\uba85\uc758 \uc554 \uc0ac\ub9dd\uc790\uac00 \ubc1c\uc0dd\ud560 \uac83\uc73c\ub85c \ucd94\uc815\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ub192\uc740 \uc554 \ubd80\ub2f4\uc740 \uc554 \uce58\ub8cc\uc81c \uc0dd\uc0b0 \uc99d\uac00\ub85c \uc774\uc5b4\uc9c0\uba70, \uc774\ub294 \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \ud68c\uc0ac\uc640\uc758 \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud574 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ub610\ud55c, 2020\ub144 5\uc6d4 \ubbf8\uad6d \uc0c1\ubb34\ubd80 \uad6d\ub9bd\ud45c\uc900\uae30\uc220\uc5f0\uad6c\uc18c(NIST)\ub294 \ud32c\ub370\ubbf9 \ub300\uc751\uc758 \uc77c\ud658\uc73c\ub85c \ubc14\uc774\uc624 \uc81c\uc57d \uc81c\uc870 \ud504\ub85c\uc81d\ud2b8\uc5d0 \uc57d 890\ub9cc \ub2ec\ub7ec\ub97c \uc9c0\uc6d0\ud588\uc2b5\ub2c8\ub2e4. \uc774 \ub610\ud55c \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub354\ubd88\uc5b4, \uc5ec\ub7ec \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc774 \uc804\ub7b5\uc801 \uc774\ub2c8\uc154\ud2f0\ube0c\ub97c \uc2e4\ud589\ud558\uba70 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2022\ub144 1\uc6d4 Recro Pharma Inc.\ub294 \ubbf8\uad6d \uc815\ubd80\uc758 \uc8fc\uc694 \ubd80\uc11c\ub85c\ubd80\ud130 \uc0c8\ub85c\uc6b4 \uc81c\ud615 \uac1c\ubc1c \ubc0f cGMP \uc81c\uc870 \uacc4\uc57d\uc744 \uc218\uc8fc\ud588\ub2e4\uace0 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc740 \uc5ec\ub7ec \uae00\ub85c\ubc8c \ubc0f \uad6d\uc81c \ud50c\ub808\uc774\uc5b4\ub4e4\uc774 \uacbd\uc7c1\ud558\ub294 \uc591\uc0c1\uc744 \ubcf4\uc785\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc740 \ud30c\ud2b8\ub108\uc2ed, \uacc4\uc57d, \ud611\ub825, \uc2e0\uc81c\ud488 \ucd9c\uc2dc, \uc9c0\ub9ac\uc801 \ud655\uc7a5, \ud569\ubcd1 \ubc0f \uc778\uc218\ub97c \ud1b5\ud574 \uc2dc\uc7a5 \uc785\uc9c0\ub97c \uac15\ud654\ud558\uae30 \uc704\ud55c \ub2e4\uc591\ud55c \uc131\uc7a5 \uc804\ub7b5\uc744 \ucc44\ud0dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub85c\ub294 Thermo Fisher Scientific (PPD, Inc.), AbbVie, Baxter BioPharma, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmbH \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2022\ub144 3\uc6d4: \uce58\ub8cc\uc81c\ub85c\uc368 \ud658\uac01\uc81c \uc0ac\uc6a9\uc5d0 \uc911\uc810\uc744 \ub454 \uac1c\ubc1c \ub2e8\uacc4 \ubc14\uc774\uc624 \uc81c\uc57d \ud68c\uc0ac\uc778 Silo Pharma, Inc.\ub294 \uc57d\ubb3c \ubc1c\uacac \ubc0f \uac1c\ubc1c \uacfc\uc815 \uc804\ubc18\uc5d0 \uac78\uccd0 \ud1b5\ud569\ub41c \uacfc\ud559 \uae30\ubc18 \uc81c\ud488 \uac1c\ubc1c \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\ub294 CRO\uc778 Frontage Laboratories\uc640 \uacc4\uc57d\uc744 \uccb4\uacb0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2022\ub144 3\uc6d4: \uc120\ub3c4\uc801\uc778 CDMO \uc911 \ud558\ub098\uc778 Piramal Pharma Limited\uc758 Pharma Solutions (PPS) \uc0ac\uc5c5\ubd80\ub294 \uc778\ub3c4 \uc544\uba54\ub2e4\ubc14\ub4dc\uc5d0 \uc704\uce58\ud55c \uc57d\ubb3c \ubc1c\uacac \uc11c\ube44\uc2a4 \uc0ac\uc774\ud2b8\uc5d0\uc11c \uae30\uc874\uc758 \uc2dc\ud5d8\uad00 \ub0b4 \uc0dd\ubb3c\ud559 \uc5ed\ub7c9\uc744 \uac15\ud654\ud560 \uc138\uacc4\uc801 \uc218\uc900\uc758 \uace0\ucc98\ub9ac\ub7c9 \uc2a4\ud06c\ub9ac\ub2dd \uc2dc\uc124\uc744 \uad6c\ucd95\ud558\uae30 \uc704\ud574 \uc218\ubc31\ub9cc \ub2ec\ub7ec\ub97c \ud22c\uc790\ud588\ub2e4\uace0 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4. \uc774 \ud655\uc7a5\uc740 \uc544\uba54\ub2e4\ubc14\ub4dc \uc0ac\uc774\ud2b8\uc5d0\uc11c \uc900\ube44\ub41c \ud654\ud569\ubb3c\uc758 1\ucc28 \ubc0f 2\ucc28 \uc2a4\ud06c\ub9ac\ub2dd \uc5ed\ub7c9\uc744 \ud06c\uac8c \uc99d\ub300\uc2dc\ud0ac \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uae00\ub85c\ubc8c \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>1. \uc11c\ub860 \ubc0f \uc5f0\uad6c \ubc94\uc704<br \/>\n\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758, \uc5f0\uad6c \ubc94\uc704\ub97c \uba85\ud655\ud788 \uc81c\uc2dc\ud558\uba70, \uacc4\uc57d \uae30\ubc18\uc73c\ub85c \uc81c\uacf5\ub418\ub294 \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4(\uc608: \ubd84\uc11d\ubc95 \uac1c\ubc1c \ub610\ub294 \uc2e0\uc57d \ubc1c\uad74)\ub97c \ud3ec\uad04\uc801\uc73c\ub85c \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>2. \uc5f0\uad6c \ubc29\ubc95\ub860 \ubc0f \uc694\uc57d<br \/>\n\uc5c4\uaca9\ud55c \uc5f0\uad6c \ubc29\ubc95\ub860\uc744 \uae30\ubc18\uc73c\ub85c \ud558\uba70, \ud575\uc2ec \ub0b4\uc6a9\uc744 \uc694\uc57d\ud55c \uc2e4\ud589 \uc694\uc57d(Executive Summary)\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \uc5ed\ud559<br \/>\n*   \uc2dc\uc7a5 \uac1c\uc694: \uc804\ubc18\uc801\uc778 \uc2dc\uc7a5 \uc0c1\ud669\uc744 \uc124\uba85\ud569\ub2c8\ub2e4.<br \/>\n*   \uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n    *   \uc758\uc57d\ud488 \uac1c\ubc1c \uc218\uc694 \uc99d\uac00<br \/>\n    *   \uac1c\ubc1c\ub3c4\uc0c1\uad6d\uc758 \ub0ae\uc740 \uc81c\uc870 \ube44\uc6a9 \ubc0f \uacbd\uc81c \uc0c1\ud669 \uac1c\uc120<br \/>\n    *   \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c(Biologics) \uc0ac\uc6a9 \uc99d\uac00<br \/>\n*   \uc2dc\uc7a5 \uc81c\uc57d:<br \/>\n    *   \uc758\uc57d\ud488 \uc2b9\uc778 \uad00\ub828 \uaddc\uc81c \ubb38\uc81c<br \/>\n    *   \uc81c\uc57d \ud68c\uc0ac\uc758 \uc81c\ud55c\uc801\uc778 \uc544\uc6c3\uc18c\uc2f1 \uc120\ud0dd<br \/>\n*   Porter\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d: \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825, \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825, \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4\ub97c \ubd84\uc11d\ud558\uc5ec \uc2dc\uc7a5\uc758 \uad6c\uc870\uc801 \ud2b9\uc131\uc744 \ud3c9\uac00\ud569\ub2c8\ub2e4.<\/p>\n<p>4. \uc2dc\uc7a5 \uc138\ubd84\ud654 (\uac00\uce58 \uae30\uc900 &#8211; USD \ubc31\ub9cc)<br \/>\n\uc2dc\uc7a5\uc740 \uc81c\uc870 \uc11c\ube44\uc2a4, \uc5f0\uad6c \uc11c\ube44\uc2a4, \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \uc788\uc73c\uba70, \uac01 \uc138\uadf8\uba3c\ud2b8\uc758 \uc2dc\uc7a5 \uaddc\ubaa8(USD \ubc31\ub9cc) \ubc0f \ucd94\uc815\uce58\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc870 \uc11c\ube44\uc2a4\ubcc4:<br \/>\n    *   API\/\uc6d0\ub8cc\uc758\uc57d\ud488 (API\/Bulk Drugs)<br \/>\n    *   \ucca8\ub2e8 \uc57d\ubb3c \uc804\ub2ec \uc81c\ud615 \ud3ec\uc7a5 (Advanced Drug Delivery Formulations Packaging)<br \/>\n    *   \ud3ec\uc7a5 (Packaging)<br \/>\n    *   \uc644\uc81c \uc758\uc57d\ud488 \uc81c\ud615 (Finished Dose Formulations): \uace0\ud615 \uc81c\ud615, \uc561\uc0c1 \uc81c\ud615, \ubc18\uace0\ud615 \uc81c\ud615<br \/>\n*   \uc5f0\uad6c \uc11c\ube44\uc2a4\ubcc4:<br \/>\n    *   \uc885\uc591\ud559 (Oncology)<br \/>\n    *   \ubc31\uc2e0 (Vaccines)<br \/>\n    *   \uc5fc\uc99d \ubc0f \uba74\uc5ed\ud559 (Inflammation and Immunology)<br \/>\n    *   \uc2ec\uc7a5\ud559 (Cardiology)<br \/>\n    *   \uc2e0\uacbd\uacfc\ud559 (Neuroscience)<br \/>\n    *   \uae30\ud0c0 \uc5f0\uad6c \uc11c\ube44\uc2a4<br \/>\n*   \uc9c0\uc5ed\ubcc4:<br \/>\n    *   \ubd81\ubbf8 (\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54)<br \/>\n    *   \uc720\ub7fd (\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778, \uae30\ud0c0 \uc720\ub7fd)<br \/>\n    *   \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 (\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ud55c\uad6d, \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591)<br \/>\n    *   \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 (GCC, \ub0a8\uc544\ud504\ub9ac\uce74, \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74)<br \/>\n    *   \ub0a8\ubbf8 (\ube0c\ub77c\uc9c8, \uc544\ub974\ud5e8\ud2f0\ub098, \uae30\ud0c0 \ub0a8\ubbf8)<\/p>\n<p>5. \uacbd\uc7c1 \ud658\uacbd<br \/>\n\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc744 \ub2e4\ub8e8\uba70, \ube44\uc988\ub2c8\uc2a4 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 Thermo Fisher Scientific (PPD, Inc.), AbbVie, Baxter BioPharma, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmbH, Lonza AG, Aurigene Pharmaceutical Services Ltd., Sterling Pharma Solutions, Symbiosis Pharmaceutical Services, Piramal Pharma Solutions, Evonik Industries AG, Labcorp Drug Development \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>6. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \ub3d9\ud5a5<br \/>\n\uc2dc\uc7a5 \ub0b4 \uc7a0\uc7ac\uc801 \uae30\ud68c\uc640 \ud5a5\ud6c4 \ud2b8\ub80c\ub4dc\ub97c \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>7. \ubcf4\uace0\uc11c\uc758 \uc8fc\uc694 \uc9c8\ubb38 \ub2f5\ubcc0 \ubc0f \uc608\uce21<br \/>\n*   \uc2dc\uc7a5 \uaddc\ubaa8: \uae00\ub85c\ubc8c \uc81c\uc57d \uc704\ud0c1 \uc0dd\uc0b0 \ubc0f \uc5f0\uad6c \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc8fc\uc694 \uae30\uc5c5: Thermo Fisher Scientific (PPD, Inc.), AbbVie, Baxter BioPharma, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmbH \ub4f1\uc774 \uc8fc\uc694 \uae30\uc5c5\uc785\ub2c8\ub2e4.<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \ucd94\uc815\ub429\ub2c8\ub2e4.<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728 \uc9c0\uc5ed: 2025\ub144\uc5d0\ub294 \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   \ubcf4\uace0\uc11c \uae30\uac04: 2019\ub144\ubd80\ud130 2024\ub144\uae4c\uc9c0\uc758 \uacfc\uac70 \uc2dc\uc7a5 \uaddc\ubaa8\uc640 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \uc608\uce21\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-57888","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/57888"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=57888"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/57888\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=57888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=57888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=57888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}